Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 902

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Dementia and Cognitive Impairment

Open access
Hugo, Julie, Ganguli, Mary·2014·Clinics in Geriatric Medicine
DOI 10.1016/j.cger.2014.04.001
Open this paper in CoChat — free account

Abstract

Synopsis Clinicians can diagnose the syndromes of dementia (major neurocognitive disorder) and mild cognitive impairment (mild neurocognitive disorder) based on history, examination, and appropriate objective assessments, using standard criteria such as DSM-5. They can then diagnose the etiological subtypes of these syndromes using standard criteria for each of them. Brain imaging and biomarkers are gaining ground for the differential diagnoses among the different disorders. Treatments for the most part are still symptomatic.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cger.2014.04.001

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 35 references

Research works printed but not linked: 73

  1. Murphy, 2013, Division of vital statistics. Deaths: final data for 2010, Natl Vital Stat Rep, 61, 1
  2. Thies, 2013, 2013 Alzheimer’s disease facts and figures, Alzheimers Dement, 9, 208, 10.1016/j.jalz.2013.02.003 · DOI · Paper page
  3. Jorm, 1998, The incidence of dementia: a meta-analysis, Neurology, 51, 728, 10.1212/WNL.51.3.728 · DOI · Paper page
  4. Matthews, 2013, A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the cognitive function and ageing study I and II, Lancet, 382, 1405, 10.1016/S0140-6736(13)61570-6 · DOI · Paper page
  5. Gurland, 1999, Rates of dementia in three ethnoracial groups, Int J Geriatr Psychiatry, 14, 481, 10.1002/(SICI)1099-1166(199906)14:6<481::AID-GPS959>3.0.CO;2-5 · DOI · Paper page
  6. Hall, 2009, Prevalence rates for dementia and Alzheimer's disease in African Americans: 1992 versus 2001, Alzheimers Dement, 5, 227, 10.1016/j.jalz.2009.01.026 · DOI
  7. Graves, 1996, Prevalence of dementia and its subtypes in the Japanese American population of King County, Washington state, Am J Epidemiol, 144, 760, 10.1093/oxfordjournals.aje.a009000 · DOI · Paper page
  8. Canadian Study of Health and Aging Working Group, 1994, Canadian Study of Health and Aging: study methods and prevalence of dementia, Can Med Assoc J, 150, 899
  9. Aarsland, 2005, A symptomatic review of prevalence studies of dementia in Parkinson’s disease, Mov Disord, 20, 1255, 10.1002/mds.20527 · DOI · Paper page
  10. Zaccai, 2005, A systematic review of prevalence and incidence studies of dementia with Lewy bodies, Age Ageing, 34, 561, 10.1093/ageing/afi190 · DOI · Paper page
  11. Rosso, 2003, Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study, Brain, 126, 2016, 10.1093/brain/awg204 · DOI · Paper page
  12. Ward, 2012, Mild cognitive impairment: disparity of incidence and prevalence estimates, Alzheimers Dement, 8, 14, 10.1016/j.jalz.2011.01.002 · DOI · Paper page
  13. Rocca, 2011, Trends in the incidence and prevalence of Alzheimer’s disease, dementia, and cognitive impairment in the United States, Alzheimers Dement, 7, 80, 10.1016/j.jalz.2010.11.002 · DOI · Paper page
  14. Gao, 1998, The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis, Arch Gen Psychiatry, 55, 809, 10.1001/archpsyc.55.9.809 · DOI · Paper page
  15. Roses, 1996, Apolipoprotein E alleles as risk factors in Alzheimer’s disease, Annu Rev Med, 47, 387, 10.1146/annurev.med.47.1.387 · DOI · Paper page
  16. Srinivasan, 2006, The apolipoprotein E ε4 allele selectively increases the risk of frontotemporal lobar degeneration in males, J Neurol Neurosurg Psychiatry, 77, 154, 10.1136/jnnp.2005.063966 · DOI
  17. Schnaider Beeri, 2004, Diabetes mellitus in midlife and the risk of dementia three decades later, Neurology, 63, 1902, 10.1212/01.WNL.0000144278.79488.DD · DOI · Paper page
  18. Tilvis, 2004, Predictors of cognitive decline and mortality of aged people over a 10-year period, J Gerontol A Biol Sci Med Sci, 59, 268, 10.1093/gerona/59.3.M268 · DOI · Paper page
  19. Qui, 2006, Heart failure and risk of dementia and Alzheimer disease: a population-based cohort study, Arch Intern Med, 166, 1003, 10.1001/archinte.166.9.1003 · DOI · Paper page
  20. Santangeli, 2012, Atrial fibrillation and the risk of incident dementia: a meta-analysis, Heart Rhythm, 9, 1761, 10.1016/j.hrthm.2012.07.026 · DOI · Paper page
  21. de la Torre, 2012, Cardiovascular risk factors promote brain hypoperfusion leading to cognitive decline and dementia, Cardiovasc Psychiatry Neurol, 2012, 367516, 10.1155/2012/367516 · DOI · Paper page
  22. Nation, 2013, Pulse pressure is associated with Alzheimer biomarkers in cognitively normal older adults, Neurology, 81, 2024, 10.1212/01.wnl.0000436935.47657.78 · DOI
  23. Schmidt, 2002, Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study, Ann Neurol, 52, 168, 10.1002/ana.10265 · DOI · Paper page
  24. Schott, 2013, Inflammation in Alzheimer’s disease: insights from immunotherapy, Brain, 136, 2654, 10.1093/brain/awt231 · DOI
  25. Tuppo, 2005, The role of inflammation in Alzheimer’s disease, Int J Biochem Cell Biol, 37, 289, 10.1016/j.biocel.2004.07.009 · DOI · Paper page
  26. Kim, 2013, Obstructive sleep apnea as a risk factor for cerebral white matter change in a middle-aged and older general population, Sleep, 36, 709, 10.5665/sleep.2632 · DOI · Paper page
  27. Chang, 2013, Sleep apnea and the risk of dementia: a population-based 5-year follow-up study in Taiwan, PLoS One, 8, e78655, 10.1371/journal.pone.0078655 · DOI · Paper page
  28. van Kooten, 1998, Epidemiology of post-stroke dementia, Haemostasis, 28, 124
  29. Panza, 2010, Late-life depression, mild cognitive impairment, and dementia: possible continuum?, Am J Geriatr Psychiatry, 18, 98, 10.1097/JGP.0b013e3181b0fa13 · DOI · Paper page
  30. Butters, 2008, Pathways linking late-life depression to persistent cognitive impairment and dementia, Dialogues Clin Neurosci, 10, 345, 10.31887/DCNS.2008.10.3/mabutters · DOI · Paper page
  31. Beaudreau, 2008, Late-life anxiety and cognitive impairment: a review, Am J Geriatr Psychiatry, 16, 790, 10.1097/JGP.0b013e31817945c3 · DOI · Paper page
  32. Wilson, 2011, Harm avoidance and risk of Alzheimer’s disease, Psychosom Med, 73, 690, 10.1097/PSY.0b013e3182302ale · DOI
  33. Fleminger, 2003, Head injury as a risk factor for Alzheimer’s disease: the evidence 10 years on; a partial replication, J Neurol Neurosurg Psychiatry, 74, 857, 10.1136/jnnp.74.7.857 · DOI · Paper page
  34. Guo, 2000, Head injury and the risk of AD in the MIRAGE study, Neurology, 54, 1316, 10.1212/WNL.54.6.1316 · DOI · Paper page
  35. Brown, 2005, Neurodegenerative diseases: an overview of environmental risk factors, Environ Health Perspect, 113, 1250, 10.1289/ehp.7567 · DOI · Paper page
  36. Anstey, 2007, Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies, Am J Epidemiol, 166, 367, 10.1093/aje/kwm116 · DOI · Paper page
  37. Quik, 2012, Nicotine as a potential neuroprotective agent for Parkinson’s disease, Mov Disord, 27, 947, 10.1002/mds.25028 · DOI · Paper page
  38. Anttila, 2004, Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: a prospective population based study, BMJ, 329, 539, 10.1136/bmj.38181.418958.BE · DOI · Paper page
  39. Mukamal, 2003, Prospective study of alcohol consumption and risk of dementia in older adults, JAMA, 289, 1405, 10.1001/jama.289.11.1405 · DOI · Paper page
  40. Franco, 2010, Molecular mechanisms of pesticide-induced neurotoxicity: relevance to Parkinson’s disease, Chem Biol Interact, 188, 289, 10.1016/j.cbi.2010.06.003 · DOI · Paper page
  41. Meng, 2012, Education and dementia in the context of the cognitive reserve hypothesis: a systematic review with meta-analyses and qualitative analyses, PLoS One, 7, e38268, 10.1371/journal.pone.0038268 · DOI · Paper page
  42. Craik, 2010, Delaying the onset of Alzheimer disease: bilingualism as a form a cognitive reserve, Neurology, 75, 1726, 10.1212/WNL.0b013e3181fc2a1c · DOI · Paper page
  43. Bonaiuto, 1995, Education and occupation as risk factors for dementia: a population-based case control study, Neuroepidemiology, 14, 101, 10.1159/000109785 · DOI
  44. Bickel, 2009, Education, occupation, and dementia: the Bavarian School Sisters Study, Dement Geriatr Cogn Disord, 27, 548, 10.1159/000227781 · DOI
  45. Hughes, 2010, Promotion of cognitive health through activity in the aging population, Aging Health, 6, 111, 10.2217/ahe.09.89 · DOI
  46. Yip, 2005, Nonsteroidal anti-inflammatory drug use and Alzheimer’s disease risk: the MIRAGE study, BMC Geriatr, 5, 2, 10.1186/1471-2318-5-2 · DOI
  47. de Craen, 2005, Meta-analysis of nonsteroidal anti-inflammatory drug use and risk of dementia, Am J Epidemiol, 161, 114, 10.1093/aje/kwi029 · DOI
  48. Swiger, 2013, Statins and cognition: a systematic review and meta-analysis of short- and long-term cognitive effects, Mayo Clin Proc, 88, 1213, 10.1016/j.mayocp.2013.07.013 · DOI · Paper page
  49. Wong, 2013, Statins in the prevention of dementia and Alzheimer’s disease: a meta-analysis of observational studies and an assessment of confounding, Pharmacoepidemiol Drug Saf, 22, 345, 10.1002/pds.3381 · DOI
  50. Shumaker, 2003, Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women’s Health Initiative Memory Study: a randomized controlled trial, JAMA, 289, 2651, 10.1001/jama.289.20.2651 · DOI · Paper page
  51. Shumaker, 2004, Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women’s Health Initiative Memory Study, JAMA, 291, 2947, 10.1001/jama.291.24.2947 · DOI · Paper page
  52. O’Brien, 2014, Postmenopausal hormone therapy is not associated with risk of all-cause dementia and Alzheimer’s disease, Epidemiol Rev, 36, 83, 10.1093/epirev/mxt008 · DOI
  53. Shao, 2012, Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study, Neurology, 79, 1846, 10.1212/WNL.0b013e318271f823 · DOI · Paper page
  54. Whitmer, 2011, Timing of hormone therapy and dementia: the critical window theory revisited, Ann Neurol, 69, 163, 10.1002/ana.22239 · DOI · Paper page
  55. Zandi, 2002, Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study, JAMA, 288, 2123, 10.1001/jama.288.17.2123 · DOI · Paper page
  56. Ruitenberg, 2002, Alcohol consumption and risk of dementia: the Rotterdam Study, Lancet, 359, 281, 10.1016/S0140-6736(02)07493-7 · DOI · Paper page
  57. Ganguli, 2005, Alcohol consumption and cognitive function in late life: a longitudinal community study, Neurology, 65, 1210, 10.1212/01.wnl.0000180520.35181.24 · DOI · Paper page
  58. Crooks, 2008, Social network, cognitive function, and dementia incidence among elderly women, Am J Public Health, 98, 1221, 10.2105/AJPH.2007.115923 · DOI · Paper page
  59. Wang, 2002, Late-life engagement in social and leisure activities is associated with a decreased risk of dementia: a longitudinal study from The Kungsholmen Project, Am J Epidemiol, 155, 1081, 10.1093/aje/155.12.1081 · DOI · Paper page
  60. Fratiglioni, 2004, An active and socially integrated lifestyle in late life might protect against dementia, Lancet Neurol, 3, 343, 10.1016/S1474-4422(04)00767-7 · DOI · Paper page
  61. Borson, 2000, The mini-cog: a cognitive ‘vital signs’ measure for dementia screening in multi-lingual elderly, Int J Geriatr Psychiatry, 15, 1021, 10.1002/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO;2-6 · DOI · Paper page
  62. Brookmeyer, 2002, Survival following a diagnosis of Alzheimer disease, Arch Neurol, 59, 1764, 10.1001/archneur.59.11.1764 · DOI · Paper page
  63. Helzner, 2008, Survival in Alzheimer disease: a multiethnic, population-based study of incident cases, Neurology, 71, 1489, 10.1212/01.wnl.0000334278.11022.42 · DOI · Paper page
  64. Sneed, 2011, The vascular depression hypothesis: an update, Am J Geriatr Psychiatry, 19, 99, 10.1097/JGP.0b013e318202fc8a · DOI
  65. Rabinovici, 2010, Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management, CNS Drugs, 24, 375, 10.2165/11533100-000000000-00000 · DOI · Paper page
  66. Brown, 2010, The prion diseases, J Geriatr Psychiatry Neurol, 23, 277, 10.1177/0891988710383576 · DOI
  67. Press D, Alexander M. Cholinesterase inhibitors in the treatment of dementia. In: Basow DS, editor. UpToDate. Waltham (MA): UpToDate. Available at: http://www.uptodate.com/contents/cholinesterase-inhibitors-in-the-treatment-of-dementia? Accessed December 17, 2013.
  68. Emre, 2004, Rivastigmine for dementia associated with Parkinson’s disease, N Engl J Med, 351, 2509, 10.1056/NEJMoa041470 · DOI · Paper page
  69. Maidment, 2006, Cholinesterase inhibitors for Parkinson's disease dementia, Cochrane Database Syst Rev, 10.1002/14651858.CD004747.pub2 · DOI
  70. McKeith, 2004, Dementia with Lewy bodies, Lancet Neurol, 3, 19, 10.1016/S1474-4422(03)00619-7 · DOI · Paper page
  71. Russ, 2012, Cholinesterase inhibitors for mild cognitive impairment, Cochrane Database Syst Rev, 10.1002/14651858.CD009132.pub2 · DOI · Paper page
  72. McShane, 2006, Memantine for dementia, Cochrane Database Syst Rev, 10.1002/14651858.CD003154.pub5 · DOI · Paper page
  73. Gareri, 2014, Use and safety of antipsychotics in behavioral disorders in elderly people with dementia, J Clin Psychopharmacol, 34, 109, 10.1097/JCP.0b013e3182a6096e · DOI

Cited by

See all 902

Metadata

Authors
Hugo, J., & Ganguli, M.
Venue
Clinics in Geriatric Medicine
Publisher
Elsevier BV
Published
2014-08
Volume
30
Issue
3
Pages
421-442
ISSN
0749-0690 (ISSN-L)
DOI
10.1016/j.cger.2014.04.001
OpenAlex
W181547059
Cited by
902
References
35
FWCI
12.80
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dementia and Cognitive Impairment. https://app.cochat.ai/papers/10.1016/j.cger.2014.04.001
The paper
Hugo, J., & Ganguli, M. (2014). Dementia and Cognitive Impairment. Clinics in Geriatric Medicine. https://doi.org/10.1016/j.cger.2014.04.001

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.